Ekomed LLC   Report issue

For profit Phase 2 Phase 3
Founded: Kiev Ukraine (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2010
NCT01061593
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Ekomed LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

immunoxel (1 trial)

Drugs in Phase 2 Trials (1)

THYTOCONCENTRATES (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometriosis (Phase 2)

Tuberculosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2